Literature DB >> 7508885

Expression of the myelomonocytic antigens CD36 and L1 by keratinocytes in squamous intraepithelial lesions of the cervix.

N Coleman1, M A Stanley.   

Abstract

The keratinocytes in squamous intraepithelial lesions (SILs) of the cervix show altered expression of a number of molecules involved both in the control of growth and differentiation and in cell surface interactions, particularly with components of the immune system. We have used tissue biopsies and in vitro model systems to investigate the expression in SILs of the molecules CD36 and L1, which are predominantly expressed by myelomonocytic cells but which also have functional roles in keratinocyte biology. Whereas the L1 protein (defined by the monoclonal antibody Mac387) was expressed by suprabasal and superficial cells in 12 of 12 cases of normal cervix (NCx) and in 14 of 14 cases of low-grade SILs (LG-SILs), in two of 16 cases of high-grade SILs (HG-SILs) it was entirely absent and in the remainder it was restricted to the most superficial layers. When an arbitrary grading scale was applied, L1 expression in HG-SILs proved to be significantly lower than in LG-SILs (P < .01) or in cases of NCx (P < .01). CD36 was expressed by superficial cells in four of 12 cases of NCx, in six of 14 LG-SILs, and none of 16 cases of HG-SILs (when graded, LG-SILs v HG-SILs = P < .05). The mechanisms underlying the expression of both molecules were investigated by growth in organotypic tissue culture of normal ectocervical epithelium and the cervical keratinocyte cell lines W12 (a model for LG-SILs) and CaSki and SiHa (models for HG-SILs). L1 was diffusely expressed by NCx cells and the W12 cell line, although its expression in the CaSki and SiHa cell lines was much more irregular and restricted. CD36 was occasionally present on the surface of superficial NCx and W12 cells, but was absent from CaSki and SiHa cells. Neither molecule could be induced by treatment of the cells with interferon-gamma. These data suggest that the expression of CD36 and L1 by cervical keratinocytes is related to their differentiation status rather than representing an effect of exogenous factors, such as those released by the immune cell infiltrate associated with SILs. CD36 may function as an immunoregulatory molecule on cervical keratinocytes in SILs, while L1 is more likely to be involved in the intracellular regulation of cell proliferation and maturation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7508885     DOI: 10.1016/0046-8177(94)90174-0

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  9 in total

Review 1.  Functional and clinical aspects of the myelomonocyte protein calprotectin.

Authors:  B Johne; M K Fagerhol; T Lyberg; H Prydz; P Brandtzaeg; C F Naess-Andresen; I Dale
Journal:  Mol Pathol       Date:  1997-06

2.  S100A8/A9 regulates MMP-2 expression and invasion and migration by carcinoma cells.

Authors:  Emmanuel J Silva; Prokopios P Argyris; Xianqiong Zou; Karen F Ross; Mark C Herzberg
Journal:  Int J Biochem Cell Biol       Date:  2014-09-16       Impact factor: 5.085

Review 3.  Calprotectin and the Initiation and Progression of Head and Neck Cancer.

Authors:  P P Argyris; Z M Slama; K F Ross; A Khammanivong; M C Herzberg
Journal:  J Dent Res       Date:  2018-02-14       Impact factor: 6.116

4.  Inverse modulation of intraepithelial Langerhans' cells and stromal macrophage/dendrocyte populations in human papillomavirus-associated squamous intraepithelial lesions of the cervix.

Authors:  W al-Saleh; P Delvenne; J E Arrese; A F Nikkels; G E Piérard; J Boniver
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

5.  Identification and validation of genes involved in cervical tumourigenesis.

Authors:  Thangarajan Rajkumar; Kesavan Sabitha; Neelakantan Vijayalakshmi; Sundersingh Shirley; Mayil Vahanan Bose; Gopisetty Gopal; Ganesharaja Selvaluxmy
Journal:  BMC Cancer       Date:  2011-02-22       Impact factor: 4.430

6.  S100A8/A9 (calprotectin) negatively regulates G2/M cell cycle progression and growth of squamous cell carcinoma.

Authors:  Ali Khammanivong; Chengxing Wang; Brent S Sorenson; Karen F Ross; Mark C Herzberg
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

7.  Lymphatic vessel density and function in experimental bladder cancer.

Authors:  Marcia R Saban; Rheal Towner; Nataliya Smith; Andrew Abbott; Michal Neeman; Carole A Davis; Cindy Simpson; Julie Maier; Sylvie Mémet; Xue-Ru Wu; Ricardo Saban
Journal:  BMC Cancer       Date:  2007-11-29       Impact factor: 4.430

8.  Involvement of calprotectin (S100A8/A9) in molecular pathways associated with HNSCC.

Authors:  Ali Khammanivong; Brent S Sorenson; Karen F Ross; Erin B Dickerson; Rifat Hasina; Mark W Lingen; Mark C Herzberg
Journal:  Oncotarget       Date:  2016-03-22

9.  HPV16 oncogene expression levels during early cervical carcinogenesis are determined by the balance of epigenetic chromatin modifications at the integrated virus genome.

Authors:  I J Groves; E L A Knight; Q Y Ang; C G Scarpini; N Coleman
Journal:  Oncogene       Date:  2016-02-15       Impact factor: 9.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.